Newly published data from USC has shown a stem-cell derived implant designed to improve vision for patients suffering from age-related macular degeneration can safely be inserted into the eye and without the need for long-term immunosuppressants.
John Carpten and Peter Kuhn will serve in the research effort aimed at reducing the national cancer death rate by 50% over the next 25 years.
The American Association for the Advancement of Science (AAAS) has elected three USC faculty to become AAAS Fellows in 2021: Andrea Armani, Yannis Yortsos, and Mark Humayun.
Dr. Humayun has devoted much of his career to clinical and scientific research in ophthalmology and bioengineering, becoming both a biomedical engineer and professor of ophthalmology.
President Joe Biden has appointed John Carpten to serve as chair of the administration’s National Cancer Advisory Board, which plays an important role in guiding the director of the National Cancer Institute in setting the course for the national cancer research program.
A team of scientists at the Keck School of Medicine of USC has created what could be a key building block for assembling a synthetic kidney.
This year’s TAG awards total $250,000 and will fund five projects in life sciences and physical sciences across a diverse range of fields at four USC schools: Dornsife, Keck, Pharmacy, and Viterbi.
A new study by Keck School of Medicine (KSOM) researchers reveals how therapies targeting a molecular chaperone called GRP78 might offer additional protection against COVID-19 and other coronaviruses that emerge in the future.
About four percent of Americans will develop colorectal cancer at some point in their life, according to the American Cancer Society, and nearly 150,000 cases are diagnosed each year.
John D. Carpten, PhD, of the Keck School of Medicine of USC has been named to the 2021 class of fellows of the American Association for Cancer Research’s AACR Academy.